🟢 Kyndryl Holdings is trading 4.09% up in pre-market; catalyst remains unclear

Kyndryl Holdings is trading at $13.24, up +4.09% in pre-market, with the catalyst unclear.

• No fresh company-specific announcement or earnings release was found for August 18, 2026; the latest identified disclosures were first-quarter results on August 5 and a Healthcare IT Leaders acquisition agreement announced August 10.
• The gain is occurring despite weaker technology-sector and broader-market futures, so it is not clearly macro-driven.
• Recent cybersecurity and earnings concerns appear associated with earlier weakness, not this pre-market rise.